---
figid: PMC9393262__fimmu-13-916778-g001
figtitle: 'Th2A cells: The pathogenic players in allergic diseases'
organisms:
- Arachis hypogaea
- Erythroxylum coca
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Pyroglyphidae
pmcid: PMC9393262
filename: fimmu-13-916778-g001.jpg
figlink: /pmc/articles/PMC9393262/figure/f1/
number: F1
caption: The signaling pathway of Th2A cells. The interaction of ST2 with IL-33 recruits
  MYD88 to activate TRAF6 by IRAK, leading to the activation of NF-kB released from
  the IKK complex. After CD161 combination with LLT1, aSMase is recruited to catalyze
  SM into ceramide, resulting in the aggregation in the membrane and inside the cells
  to mediate distinct functions. CRTH2 activated by PGD2 reduces cAMP production,
  thereby inhibiting NF-κB activity and phosphorylates CREB protein. Meanwhile, the
  same as TCR, CRTH2 also activates PKCθ, ERK/MAPK, and Ca2+ calcineurin signaling
  pathways to mediate cell survival, proliferation, and cytokine production through
  the transcription factor NF-κB, AP-1, and NFAT. Arachidonic acid derived from phospholipids
  is converted to PGH2 by COX-1/2, which can then be catalyzed into PGD2 by HPGDS.
  IKK, IκB kinase; ZAP70, ζ-chain associated protein kinase of 70 kDa; PLCγ, phospholipase
  Cγ; PIP2, phosphatidylinositol bisphosphate; DAG, diacylglycerol; PKCθ, protein
  kinase Cθ; RASGRP, RAS guanyl nucleotide–releasing protein; MAPK, mitogen-activated
  protein kinase; ERK, extracellular signal-regulated kinase; IP3, inositol trisphosphate;
  cAMP, cyclic adenosine 3, 5′-monophosphate; PKA, protein kinase A; COX-1/2, cyclooxygenases
  I and II; ASM, acid sphingomyelinase; CaN, calcineurin.
papertitle: 'Th2A cells: The pathogenic players in allergic diseases.'
reftext: Ziyu Huang, et al. Front Immunol. 2022;13:916778.
year: '2022'
doi: 10.3389/fimmu.2022.916778
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: allergic disease | Th2A cells | allergen-specific Th2 cells | HPGDS | CRTH2
  | CD161 | ST2
automl_pathway: 0.9432281
figid_alias: PMC9393262__F1
figtype: Figure
organisms_ner:
- Canis lupus familiaris
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC9393262__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9393262__fimmu-13-916778-g001.html
  '@type': Dataset
  description: The signaling pathway of Th2A cells. The interaction of ST2 with IL-33
    recruits MYD88 to activate TRAF6 by IRAK, leading to the activation of NF-kB released
    from the IKK complex. After CD161 combination with LLT1, aSMase is recruited to
    catalyze SM into ceramide, resulting in the aggregation in the membrane and inside
    the cells to mediate distinct functions. CRTH2 activated by PGD2 reduces cAMP
    production, thereby inhibiting NF-κB activity and phosphorylates CREB protein.
    Meanwhile, the same as TCR, CRTH2 also activates PKCθ, ERK/MAPK, and Ca2+ calcineurin
    signaling pathways to mediate cell survival, proliferation, and cytokine production
    through the transcription factor NF-κB, AP-1, and NFAT. Arachidonic acid derived
    from phospholipids is converted to PGH2 by COX-1/2, which can then be catalyzed
    into PGD2 by HPGDS. IKK, IκB kinase; ZAP70, ζ-chain associated protein kinase
    of 70 kDa; PLCγ, phospholipase Cγ; PIP2, phosphatidylinositol bisphosphate; DAG,
    diacylglycerol; PKCθ, protein kinase Cθ; RASGRP, RAS guanyl nucleotide–releasing
    protein; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated
    kinase; IP3, inositol trisphosphate; cAMP, cyclic adenosine 3, 5′-monophosphate;
    PKA, protein kinase A; COX-1/2, cyclooxygenases I and II; ASM, acid sphingomyelinase;
    CaN, calcineurin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - IL2
  - IL4
  - IL13
  - IL5
  - CD4
  - ZAP70
  - PTGDR2
  - JUN
  - HPGDS
  - PTGS1
  - PTGS2
  - IL33
  - IL1RAP
  - MYD88
  - TRAF6
  - CXCL8
  - PROC
  - H2AC1
  - CLEC2D
  - KLRB1
  - SMPD1
  - H19
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PLCG1
  - PLCG2
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - FOS
  - FOSB
  - JUNB
  - JUND
  - PTGDS
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - COX1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - ST2
  - SULT2A1
  - IL1RL1
  - SDCBP2
  - IRAK1
  - Apc
  - H2ac1
  - Klrb1c
  - Smpd1
  - Il2
  - Il4
  - Il13
  - Il5
  - Cd4
  - H2
  - Zap70
  - Trav6-3
  - Plcb1
  - Rasgrp1
  - Ephb2
  - Mapk1
  - Ptgdr2
  - Prkcq
  - Jun
  - Ptgds
  - Gnai2
  - ac
  - Hpgds
  - Creb1
  - Pla2g2a
  - Pla2g5
  - Ptgs1
  - Ptgs2
  - Nfkb1
  - Il1rl1
  - Il33
  - Il1rap
  - Myd88
  - Irak1
  - Traf6
  - Cxcl15
---
